Your browser doesn't support javascript.
loading
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
Evans, Thomas G; Bussey, Louise; Eagling-Vose, Elizabeth; Rutkowski, Kathryn; Ellis, Chris; Argent, Chris; Griffin, Paul; Kim, Joshua; Thackwray, Susan; Shakib, Sepehr; Doughty, Julia; Gillies, John; Wu, Jian; Druce, Julian; Pryor, Melinda; Gilbert, Sarah.
Afiliação
  • Evans TG; Vaccitech, Oxford, UK. Electronic address: tom.evans@vaccitech.co.uk.
  • Bussey L; Vaccitech, Oxford, UK.
  • Eagling-Vose E; Vaccitech, Oxford, UK.
  • Rutkowski K; Vaccitech, Oxford, UK.
  • Ellis C; Vaccitech, Oxford, UK.
  • Argent C; Paratus Clinical Blacktown Clinic, Blacktown, NSW, Australia.
  • Griffin P; Rio Mater Research, Brisbane, QLD, Australia.
  • Kim J; Paratus Clinical Kanwal Clinic, Kanwal, NSW, Australia.
  • Thackwray S; University of Sunshine Coast, Sippy Downs, QLD, Australia.
  • Shakib S; CMAX, Adelaide, SA, Australia.
  • Doughty J; Clinical Network Services, Brisbane, QLD, Australia.
  • Gillies J; Clinical Network Services, Brisbane, QLD, Australia.
  • Wu J; Clinical Network Services, Brisbane, QLD, Australia.
  • Druce J; Victoria Infectious Diseases Research Laboratory, Melbourne, VIC, Australia.
  • Pryor M; 360biolabs, Melbourne, VIC, Australia.
  • Gilbert S; Jenner Institute, Oxford University, Oxford, UK.
Lancet Infect Dis ; 22(6): 857-866, 2022 06.
Article em En | MEDLINE | ID: mdl-35305317

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Idioma: En Ano de publicação: 2022 Tipo de documento: Article